. 2017 May 18;16(3):240–251. doi: 10.1002/rmb2.12037

Table 1.

Pretreatment semen parameters in patients with testicular cancer (TC)

Authors Year of study report	Patients with pre‐orchiectomy data	Sperm concentration (×10⁶/mL) (range)	Sperm motility (%) (range)	Morphologically normal sperm (%) (range)
Nijman et al.23 1985	14 with TC	13.20^a (0‐63)	31.0^a (0‐70)	48.0^a (30‐58)
Nijman et al.23 1985	59 controls	73.80^a (8‐185)	50.0^a (10‐80)	58.0^a (32‐77)
Botchan et al.24 1997	32 with seminoma	50.00^b (0‐230)	40.0^b (0‐60)	37.0^b (0‐57)
	22 with nonseminoma	17.00^b (0‐288)	35.0^b (0‐58)	30.0^b (0‐46)
	190 controls	175.00^b (2‐476)	50.0^b (0‐90)	44.0^b (3‐92)
Petersen et al.25 1999	63 with TC	15.00^b (0‐128)	66.0^b (0‐93)	41.0^b (19‐75)
Petersen et al.25 1999	141 controls	48.00^b (0‐402)	65.0^b (32‐100)	42.0^b (8‐65)
Williams IV et al.26 2009	179 with TC	32.90^a (1.0‐308.5)	48.5^a (1‐85)	N/A
Fraietta et al.27 2010	37 with seminoma	25.98^a (0‐145)	56.3^a (0‐88)	10.0^a (2‐21)
Fraietta et al.27 2010	63 with nonseminoma	14.46^a (0‐63.3)	54.2^a (1‐89)	8.2^a (1‐21)
Johnson et al.28 2013	134 with TC	24.80^b (0‐203)	41.5^b (0‐96)	N/A
Auger et al.29 2016	2315 with TC	19.60^b (5.4‐48.8)^c	45.0^b (30‐56)	33.0^b (19‐48)

N/A, not applicable or not available. ^aMean; ^bMedian; ^cInterquartile range.